Gastric cancer (GC) is a complex and heterogeneous disease with significant phenotypic
and genetic variation. Traditional classification systems rely mainly on the evaluation of …

Single-cell RNA sequencing (scRNA-Seq) is a recent technology that allows for the
measurement of the expression of all genes in each individual cell contained in a sample …

Simple Summary Gastric cancer is still one of the leading causes of death caused by cancer
in developing countries. The emerging role of immunotherapy in cancer treatment has led to …

Gastric cancer (GC) is a heterogeneous disease, often diagnosed at advanced stages, with
a 5-year survival rate of approximately 20%. Despite notable technological advancements in …

Gastric cancer (GC) is one of the most common cancers worldwide. Most patients are
diagnosed at the progressive stage of the disease, and current anticancer drug …

Background Gastric cancer (GC) is known for its high heterogeneity, presenting challenges
in current clinical treatment strategies. Accurate subtyping and in-depth analysis of the …

Simple Summary Gastric adenocarcinoma (GAC) is most commonly classified based on a
system developed by the Cancer Genome Atlas in 2014. However, this subtyping system …